Investor Relations

CUREXO is committed to fair and transparent business management.

Financial Statement

Unit : KRW million

100,000 80,000 60,000 40,000 20,000 0
Asset
  • 2023 107,370
  • 2024 102,583
  • 2025 101,137
100,000 80,000 60,000 40,000 20,000 0
Liability
  • 2023 6,941
  • 2024 9,202
  • 2025 4,888
100,000 80,000 60,000 40,000 20,000 0
Equity
  • 2023 100,428
  • 2024 93,380
  • 2025 96,248
100,000 80,000 60,000 40,000 20,000 0
Sales
  • 2023 72,882
  • 2024 55,531
  • 2025 74,520

Balance Sheet

Unit : KRW million

Classification 2023 2024 2025
Current Asset 90,831 87,942 87,129
Non-current Asset 16,538 14,641 14,008
Asset 107,370 102,583 101,137
Current liability 4,933 7,936 4,211
Non-current liability 2,008 1,266 677
Liability 6,941 9,202 4,888
Paid in capital 20,478 20,544 20,544
Retained earnings -140,130 -149,049 -146,208
Equity 100,428 93,380 96,248

Income Statment

Unit : KRW million

Classification 2023 2024 2025
Sales 72,882 55,531 74,520
Operating income 1,135 -5,821 2,588
Pre-tax income -4,759 -8,668 3,076
Net income -4,856 -8,757 3,017